Literature DB >> 25785092

Genetic polymorphisms of IL-6 and IL-10 genes correlate with lung cancer in never-smoking Han population in China.

Ying-Min Zhang1, Yi-Min Mao1, Yu-Xia Sun1.   

Abstract

Lung cancer is one of the most common cancers in the world, especially in China. It is believed that genetic polymorphisms played a role in cancer susceptibility. Here we investigated the association of interleukin-6 (IL-6) and interleukin-10 (IL-10) gene polymorphisms with the susceptibility of lung cancer in never-smoking Chinese Han population. In this study, we performed a case-control study including 330 cases of never-smoking lung cancer patients and 336 cancer-free never-smoking controls in Chinese Han population. We used polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method to identify gene polymorphisms, and then verified by sequencing method. The results indicated that the four single nucleotide polymorphisms (IL-6 -1363T/G and -572G/C, IL-10 -819T/C and -592A/C) were genotyped by PCR-RFLP and confirmed by sequencing, and we found that the allelic frequencies of G in IL-6 -1363T/G, C in IL-10 -819T/C and C in IL-10 -592A/C were significantly increased in lung cancer patients, by comparing with the control group. However, there was no significant difference in the distribution of the IL-6 572G/C polymorphisms between patients and controls. In conclusion, the IL-6 -1363T/G, IL-10 -819T/C and IL-10 -592A/C polymorphisms are closely related to genetic susceptibility to lung cancer in never-smoking Chinese Han population, and these genetic variants might be used as molecular markers for detecting lung cancer susceptibility.

Entities:  

Keywords:  IL-10 gene; IL-6 gene; Lung cancer; cancer susceptibility; single-nucleotide polymorphisms

Year:  2015        PMID: 25785092      PMCID: PMC4358547     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  32 in total

1.  Interleukin-6 receptor gene polymorphisms and periodontitis in a non-smoking Japanese population.

Authors:  Johnah C Galicia; Hideaki Tai; Yasutaka Komatsu; Yasuko Shimada; Ikuyo Ikezawa; Hiromasa Yoshie
Journal:  J Clin Periodontol       Date:  2006-08-07       Impact factor: 8.728

2.  Suppression of EGFR-STAT3 signaling inhibits tumorigenesis in a lung cancer cell line.

Authors:  Yong-Qian Jiang; Zhi-Xiang Zhou; You-Lin Ji
Journal:  Int J Clin Exp Med       Date:  2014-08-15

Review 3.  Is there a genetic basis for lung cancer susceptibility?

Authors:  C I Amos; W Xu; M R Spitz
Journal:  Recent Results Cancer Res       Date:  1999

4.  Semi-quantitative investigation of primary tumor and bone metastasis in lung cancer patients using the PET-CT approach.

Authors:  Ozan Kandemir; Kayhan Karakuş; Ozgür Katrancioğlu; Ali Sarikaya
Journal:  Int J Clin Exp Med       Date:  2014-09-15

5.  Umbelliprenin induced production of IFN-γ and TNF-α, and reduced IL-10, IL-4, Foxp3 and TGF-β in a mouse model of lung cancer.

Authors:  Narges Khaghanzadeh; Afshin Samiei; Mohammad Ramezani; Zahra Mojtahedi; Massood Hosseinzadeh; Abbas Ghaderi
Journal:  Immunopharmacol Immunotoxicol       Date:  2013-12-11       Impact factor: 2.730

6.  Autocrine IL-8 and VEGF mediate epithelial-mesenchymal transition and invasiveness via p38/JNK-ATF-2 signalling in A549 lung cancer cells.

Authors:  Sejal Desai; S Laskar; B N Pandey
Journal:  Cell Signal       Date:  2013-05-25       Impact factor: 4.315

7.  TERT rs2736100T/G polymorphism upregulates interleukin 6 expression in non-small cell lung cancer especially in adenocarcinoma.

Authors:  Fuxia Wang; Ping Fu; Yixin Pang; Chengxiang Liu; Zhulin Shao; Jingyan Zhu; Jie Li; Ti Wang; Xia Zhang; Jie Liu
Journal:  Tumour Biol       Date:  2014-01-14

8.  Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study.

Authors:  Akbar Farjadfar; Zahra Mojtahedi; Mohammad Ali Ghayumi; Nasrollah Erfani; Mohammad Reza Haghshenas; Abbas Ghaderi
Journal:  Acta Oncol       Date:  2009       Impact factor: 4.089

9.  Brain metabolomic profiles of lung cancer patients prior to treatment characterized by proton magnetic resonance spectroscopy.

Authors:  Helene Benveniste; Shaonan Zhang; Ruth A Reinsel; Haifang Li; Hedok Lee; Mario Rebecchi; William Moore; Christoffer Johansen; Douglas L Rothman; Thomas V Bilfinger
Journal:  Int J Clin Exp Med       Date:  2012-04-06

10.  TNF-alpha, TNF-beta, IL-6, and IL-10 polymorphisms in patients with lung cancer.

Authors:  Carola Seifart; Alexandra Plagens; Astrid Dempfle; Ursula Clostermann; Claus Vogelmeier; Peter von Wichert; Ulf Seifart
Journal:  Dis Markers       Date:  2005       Impact factor: 3.434

View more
  13 in total

1.  Interleukin-10 promoter polymorphism and susceptibility to lung cancer: a systematic review and meta-analysis.

Authors:  Xiong Lan; Tian Lan; Qin Faxiang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  Interaction of tobacco chewing and smoking habit with interleukin 6 promoter polymorphism in oral precancerous lesions and oral cancer.

Authors:  Yadvendra Shahi; Sayali Mukherjee; Fahad M Samadi
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-01-27       Impact factor: 2.503

3.  IL-21 polymorphisms rs907715 and rs2221903 are associated with decreased non-small cell lung cancer susceptibility.

Authors:  Lanping Liu; Fang Shi; Shanshan Li; Xiuju Liu; Lili Wei; Jian Zhang; Xiao Ju; Jinming Yu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

4.  Characterization and Clinical Implication of Th1/Th2/Th17 Cytokines Produced from Three-Dimensionally Cultured Tumor Tissues Resected from Breast Cancer Patients.

Authors:  Anna Kiyomi; Masujiro Makita; Tomoko Ozeki; Na Li; Aiko Satomura; Sachiko Tanaka; Kenji Onda; Kentaro Sugiyama; Takuji Iwase; Toshihiko Hirano
Journal:  Transl Oncol       Date:  2015-08       Impact factor: 4.243

5.  Polymorphisms in the IL-6 and IL-6R receptor genes as new diagnostic biomarkers of acute appendicitis: a study on two candidate genes in pediatric patients with acute appendicitis.

Authors:  Sevgi Büyükbeşe Sarsu; Şenay Görücü Yılmaz; Ali Bayram; Affan Denk; Kürşat Kargun; Mehmet Ali Sungur
Journal:  Ital J Pediatr       Date:  2015-12-29       Impact factor: 2.638

6.  Distribution of allelic and genotypic frequencies of IL1A, IL4, NFKB1 and PAR1 variants in Native American, African, European and Brazilian populations.

Authors:  Marcos A T Amador; Giovanna C Cavalcante; Ney P C Santos; Leonor Gusmão; João F Guerreiro; Ândrea Ribeiro-dos-Santos; Sidney Santos
Journal:  BMC Res Notes       Date:  2016-02-16

7.  IL-10 -1082A/G, -592C/A, and -819T/C polymorphisms in association with lung cancer susceptibility: a meta-analysis.

Authors:  Liang Liu; Feng Zheng
Journal:  Onco Targets Ther       Date:  2016-10-07       Impact factor: 4.147

8.  Meta-analysis of the role of IL-6 rs1800795 polymorphism in the susceptibility to prostate cancer: Evidence based on 17 studies.

Authors:  Tong-Zu Liu; Zhong-Qiang Guo; Ting Wang; Yue Cao; Di Huang; Xing-Huan Wang
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

9.  Evaluation of efficacy and safety of minimally invasive segmentectomy in the treatment of lung cancer.

Authors:  Changqing Shao; Cuiling Zheng; Wanshu Yan; Yi Shen; Zhixue Zhang
Journal:  Oncol Lett       Date:  2018-04-13       Impact factor: 2.967

10.  Association of three promoter polymorphisms in interleukin-10 gene with cancer susceptibility in the Chinese population: a meta-analysis.

Authors:  Ping Wang; Junling An; Yanfeng Zhu; Xuedong Wan; Hongzhen Zhang; Shoumin Xi; Sanqiang Li
Journal:  Oncotarget       Date:  2017-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.